RB1 and prostate cancer: To examine whether the combination of palbociclib and autophagy inhibitor is effective in other solid tumours, we examined several ovarian, pancreatic, lung, colorectal and prostate cancer cell lines with varied expression levels of Rb and cyclin E (Fig. 5i).